L Brands falls after guidance update

Victoria’s Secret owner L Brands’ (LB) stock is sliding after management revised its 1Q18 profit expectations along with its monthly sales report earlier today.

The company posted a 4% YoY (year-over-year) increase in total sales to $751.6 million for the month ended May 5. Comparable sales for the period stood flat and were negatively impacted by around three percentage points from the Easter holiday.

For the first quarter of 2018, sales increased 8% YoY to $2.63 billion—better than analysts’ forecast of a 6.4% YoY jump to $2.59 billion. Same-store sales for the period improved around 3%, driven by an 8% jump in Bath & Body Works comps and a 1% increase in Victoria’s Secret comps.

This Is Why L Brands Stock Is Falling Today

What’s troubling investors?

The company, however, said it expects earnings per share to lie at the lower end of its 15 cents–20 cents guidance range. The announcement triggered a slide in L Brands’ already beaten-down stock.

Its share price tumbled around 10% to 30.74 by 10:45 EST. The company has already hit a six-year low.

L Brands is among the worst-performing apparel stocks this year. Its share price was down more than 43% YTD (year-to-date) as of yesterday. The company is slated to report its first-quarter results on May 23.

Latest articles

Last week (ended August 16) was rough for Canopy Growth (WEED)(CGC) stock. It fell about 14% after the company's fiscal 2020 first-quarter earnings report.

Apple shares rose close to 3% in early hour trading on Monday. So, why is Apple stock trading higher? The market sentiment might have turned positive.

Huawei plans to launch its own mapping service as soon as this October. But Huawei’s Map Kit will initially not be a consumer mapping service.

Ford stock fell 5.2% last week. The fall extended the stock’s decline to 13.3% since its second-quarter results on July 24.

In April, Amazon announced its plan to transform its free two-day shipping program to a free one-day shipping program for its Prime customers.

Cannabis companies face regulatory challenges. Recently, CannTrust (CTST) didn't comply with Health Canada’s regulations.